FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nancy Davidson

Research Profile

Disorders

Procedures

Chemicals & Drugs

Anatomy

Physiology

Concepts & Ideas

Co-author Network

Publications

TOP 3
Lawrence J Solin; Joseph A Sparano; William C Wood; Carl Yoshizawa; Frederick L Baehner; Steven M Butler; Diana B Cherbavaz; Nancy E Davidson; Robert Gray; Lorie L Hughes; James N Ingle; David L Page; Edith A Perez; Steven Shak; George W Sledge; Sunil Badve
A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
MICHELLE RUDEK-RENAUT; Vered Stearns; Stanley P Watkins; Laurie A Wright; Ming Zhao; Deborah K Armstrong; Roisin M Connolly; Nancy E Davidson; John H Fetting; Elizabeth Garrett-Mayer; Janelle M Hoskins; Stacie C Jeter; Howard L McLeod; Antonio C Wolff
Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer.
Amye J Tevaarwerk; Lynne I Wagner; Nancy E Davidson; John H Fetting; Lori J Goldstein; Robert J Gray; Kathy D Miller; Bryan P Schneider; Mary Lou Smith; Joseph A Sparano
Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 years.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nancy Davidson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Lawrence J Solin; Joseph A Sparano; William C Wood; Carl Yoshizawa; Frederick L Baehner; Steven M Butler; Diana B Cherbavaz; Nancy E Davidson; Robert Gray; Lorie L Hughes; James N Ingle; David L Page; Edith A Perez; Steven Shak; George W Sledge; Sunil Badve
A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Journal of the National Cancer Institute 2013;105(10):701-10.
2013: MICHELLE RUDEK-RENAUT; Vered Stearns; Stanley P Watkins; Laurie A Wright; Ming Zhao; Deborah K Armstrong; Roisin M Connolly; Nancy E Davidson; John H Fetting; Elizabeth Garrett-Mayer; Janelle M Hoskins; Stacie C Jeter; Howard L McLeod; Antonio C Wolff
Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer.
Breast cancer research and treatment 2013;139(1):135-43.
2013: Amye J Tevaarwerk; Lynne I Wagner; Nancy E Davidson; John H Fetting; Lori J Goldstein; Robert J Gray; Kathy D Miller; Bryan P Schneider; Mary Lou Smith; Joseph A Sparano
Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 years.
Cancer 2013;119(6):1140-8.
2013: Nancy E Davidson
Fifteen years of anti-HER2 therapy.
Oncology (Williston Park, N.Y.) 2013;27(3):151.
2013: James Khatcheressian; Hyman B Muss; Thomas J Smith; Mark R Somerfield; Victor G Vogel; Antonio C Wolff; Elissa Bantug; Nancy E Davidson; Laura J Esserman; Eva Grunfeld; Francine Halberg; Alexander Hantel; N Lynn Henry; Patricia Hurley
Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(7):961-5.
2013: Paul E Goss; James N Ingle; Robert B Livingston; Silvana Martino; Hyman Muss; Edith A Perez; Kathleen I Pritchard; Nicholas J Robert; Lois E Shepherd; David A Cameron; Y Chavarri-Guerra; Nancy E Davidson; T Whelan; Dongsheng Tu
Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(2):355-61.
2013: Priscilla F McAuliffe; Steven D Shapiro; Sandra Danoff; Nancy E Davidson
Treatment for breast cancer: is time really of the essence?
Journal of the National Cancer Institute 2013;105(2):80-2.
2012: Rohit Bhargava; Adam M Brufsky; Nancy E Davidson
Prognostic/Predictive immunohistochemistry assays for estrogen receptor-positive breast cancer: back to the future?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(36):4451-3.
2012: Joseph A Sparano; Vered Stearns; Molin Wang; Antonio C Wolff; William C Wood; Fengmin Zhao; John H Fetting; Jennifer A Ligibel; Silvana Martino; Edith A Perez; Tom Saphner; George W Sledge; Nancy E Davidson
Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer.
Cancer 2012;118(23):5937-46.
2012: Qingsong Zhu; Lihua Jin; Robert A Casero; Nancy E Davidson; Yi Huang
Role of ornithine decarboxylase in regulation of estrogen receptor alpha expression and growth in human breast cancer cells.
Breast cancer research and treatment 2012;136(1):57-66.
2012: Bryan P Schneider; George W Sledge; Nancy E Davidson; Vicky Jones; Silvana Martino; Edith A Perez; Tom Saphner; Vered Stearns; Molin Wang; Antonio C Wolff; William C Wood; Fengmin Zhao; Joseph A Sparano
Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(25):3051-7.
2012: Peter H Shaw; Hussein Tawbi; Anne Welsh; Michael Boyiadzis; Nancy E Davidson; Aimee Kemerer; A Kim Ritchey
Improved clinical trial enrollment in adolescent and young adult (AYA) oncology patients after the establishment of an AYA oncology program uniting pediatric and medical oncology divisions.
Cancer 2012;118(14):3614-7.
2012: Joseph A Sparano; George W Sledge; Nancy E Davidson; Lori J Goldstein; Robert Gray
TOP2A RNA expression and recurrence in estrogen receptor-positive breast cancer.
Breast cancer research and treatment 2012;134(2):751-7.
2012: Lawrence J Solin; Sunil Badve; Frederick L Baehner; Nancy E Davidson; Lori J Goldstein; Robert Gray; Silvana Martino; Edith A Perez; Abram Recht; Steven Shak; Lawrence N Shulman; George W Sledge; Joseph A Sparano
Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study.
Breast cancer research and treatment 2012;134(2):683-92.
2012: Dong Hu; Yi Huang; Nancy E Davidson; Zhuan Zhou; Yong Wan
Novel insight into KLF4 proteolytic regulation in estrogen receptor signaling and breast carcinogenesis.
The Journal of biological chemistry 2012;287(17):13584-97.
2012: Shannon Puhalla; Saveri Bhattacharya; Nancy E Davidson
Hematopoietic growth factors: personalization of risks and benefits.
Molecular oncology 2012;6(2):237-41.
2012: Shannon Puhalla; Saveri Bhattacharya; Nancy E Davidson
Hormonal therapy in breast cancer: a model disease for the personalization of cancer care.
Molecular oncology 2012;6(2):222-36.
2012: Joseph A Sparano; Vered Stearns; Molin Wang; Antonio C Wolff; William C Wood; Fengmin Zhao; Jennifer A Ligibel; Silvana Martino; Edith A Perez; Tom Saphner; George W Sledge; Nancy E Davidson
Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial.
Journal of the National Cancer Institute 2012;104(5):406-14.
2012: Kideok Jin; Anne Kallioniemi; Xiangjun Kong; Goran Landberg; Peter E Lobie; Xiao-Jun Ma; Marie-France Penet; Dennis C Sgroi; Tariq Shah; Zaver M Bhujwalla; Ivan Bieche; Nancy E Davidson; Yi Huang; Flonne Wildes; Xinyan Wu; Tao Zhu; Saraswati Sukumar
The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(8):2736-41.
2012: Michaela J Higgins; Stacie C Jeter; NAGI KHOURI; Pendleton P Powers; Tatiana M Prowell; James M Rae; Shannon A Slater; Deborah K Armstrong; Amanda Blackford; Roger S Blumenthal; Celia Byrne; Nancy E Davidson; Mitchell Dowsett; Leisha A Emens; John H Fetting; Elizabeth Folkerd; Judy E Garber; Hannah Green; Jacklyn N Thibert; Antonio C Wolff; Vered Stearns
A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer.
Breast cancer research and treatment 2012;131(3):915-24.
2012: Aditya Bardia; Roger S Blumenthal; Nancy E Davidson; Andrew Defilippis; John H Fetting; David A Flockhart; Jill Hayden; Daniel F Hayes; N Lynn Henry; Stacie Jeter; Anne Nguyen; Pamela Ouyang; Anna Maria Storniolo; Karineh Tarpinian; Antonio C Wolff; Zhe Zhang; Erin T Arieas; Deborah K Armstrong; M Dominique Ashen; Vered Stearns
Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer.
Breast cancer research and treatment 2012;131(3):907-14.
2012: Qingsong Zhu; Nancy E Davidson; Yi Huang; Laurence J Marton; Patrick M Woster; Robert A Casero
Polyamine analogs modulate gene expression by inhibiting lysine-specific demethylase 1 (LSD1) and altering chromatin structure in human breast cancer cells.
Amino acids 2012;42(2-3):887-98.
2012: Abena S Agyeman; Raghothama Chaerkady; Nancy E Davidson; Akhilesh Pandey; Patrick G Shaw; Kala Visvanathan; Thomas W Kensler
Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles.
Breast cancer research and treatment 2012;132(1):175-87.
2012: Yi Huang; Patrick G Shaw; Shauna N Vasilatos; Lamia Boric; Nancy E Davidson
Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells.
Breast cancer research and treatment 2012;131(3):777-89.
2012: Edith A Perez; Monica M Reinholz; Kathleen S Tenner; Nancy E Davidson; Amylou Dueck; Julie Gralow; Lyndsay N Harris; David W Hillman; Robert B Jenkins; Leila A Kutteh; Ann E McCullough; Beiyun Chen
Predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteria.
Journal of the National Cancer Institute 2012;104(2):159-62.
2011: Edith A Perez; Thomas M Pisansky; Vera J Suman; Daniel W Visscher; Joanne Zujewski; Beiyun Chen; Shaker R Dakhil; Nancy E Davidson; Julie R Gralow; James N Ingle; Peter A Kaufman; Alvaro Moreno-Aspitia; Robert B Jenkins
Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(34):4491-7.
2011: Tatiana M Prowell; Todd C Skaar; Karineh S Tarpinian; Antonio C Wolff; Laurie A Wright; Deborah K Armstrong; Amanda L Blackford; Celia Byrne; Nancy E Davidson; Michele G Donehower; Mitchell Dowsett; Leisha A Emens; John H Fetting; Elizabeth Folkerd; Elizabeth Garrett-Mayer; Stacie C Jeter; NAGI KHOURI; Pendleton P Powers; Vered Stearns
Changes in breast density and circulating estrogens in postmenopausal women receiving adjuvant anastrozole.
Cancer prevention research (Philadelphia, Pa.) 2011;4(12):1993-2001.
2011: Joseph A Sparano; Lawrence N Shulman; Paraic Kenny; George W Sledge; Diana Brassard; Lori J Goldstein; Roberto Bugarini; Steven Shak; Silvana Martino; Sunil Badve; Steve Rowley; Barrett H Childs; Nancy E Davidson; Frederick L Baehner; Edith A Perez; Robert Gray
Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(22):7194-203.
2011: Jennifer J Griggs; N Lynn Henry; Clifford A Hudis; James Khatcheressian; Ann H Partridge; Ann Alexis Prestrud; Mark R Somerfield; Holly Anderson; Nancy E Davidson
American Society of Clinical Oncology endorsement of the cancer care Ontario practice guideline on adjuvant ovarian ablation in the treatment of premenopausal women with early-stage invasive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(29):3939-42.
2011: Shannon Puhalla; Rachel C Jankowitz; Nancy E Davidson
Adjuvant endocrine therapy for breast cancer: don't ditch the switch!
Journal of the National Cancer Institute 2011;103(17):1280-2.
2011: Edith A Perez; Edward H Romond; Vera J Suman; Nancy E Davidson; Charles E Geyer; Jong-Hyeon Jeong; Peter A Kaufman; Eleftherios P Mamounas; Silvana Martino; Norman Wolmark
Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(25):3366-73.
2011: Nancy E Davidson; Thomas W Kensler
"MAPping" the course of chemoprevention in breast cancer.
The New England journal of medicine 2011;364(25):2463-4.
2011: Patrick G Shaw; Raghothama Chaerkady; Zhen Zhang; Nancy E Davidson; Akhilesh Pandey
Monoclonal antibody cocktail as an enrichment tool for acetylome analysis.
Analytical chemistry 2011;83(10):3623-6.
2011: Roisin M Connolly; MICHELLE RUDEK-RENAUT; Elizabeth Garrett-Mayer; Stacie C Jeter; Michele G Donehower; Laurie A Wright; Ming Zhao; John H Fetting; Leisha A Emens; Vered Stearns; Nancy E Davidson; Sharyn D Baker; Antonio C Wolff
Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancer.
Breast cancer research and treatment 2011;127(1):153-62.
2011: Nancy E Davidson
HER2-targeted therapies: how far we've come--and where we're headed.
Oncology (Williston Park, N.Y.) 2011;25(5):425-6.
2011: Nancy E Davidson
Restrospective on the last quarter-century in medical oncology.
Oncology (Williston Park, N.Y.) 2011;25(5):396.
2011: Edith A Perez; Robert B Jenkins; Amylou C Dueck; Anne E Wiktor; Patrick P Bedroske; S Keith Anderson; Rhett P Ketterling; William R Sukov; Kazunori Kanehira; Beiyun Chen; Xochiquetzal J Geiger; Cathy A Andorfer; Ann E McCullough; Nancy E Davidson; Silvana Martino; George W Sledge; Peter A Kaufman; Leila A Kutteh; Julie R Gralow; Lyndsay N Harris; James N Ingle; Wilma L Lingle; Monica M Reinholz
C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(6):651-9.
2011: Yi Huang; Rachel Jankowitz; Shweta Nayak; Nancy E Davidson; Steffi Oesterreich
Epigenetics in breast cancer: what's new?
Breast cancer research : BCR 2011;13(6):225.
2011: Yi Huang; Patrick G Shaw; Nancy E Davidson
Inhibition of histone deacetylases.
Methods in molecular biology (Clifton, N.J.) 2011;791():297-311.
2010: Michael A Jacobs; Vered Stearns; Antonio C Wolff; Katarzyna J Macura; Pedram Argani; NAGI KHOURI; Theodore Tsangaris; Peter B Barker; Nancy E Davidson; Zaver M Bhujwalla; David A Bluemke; Ronald Ouwerkerk
Multiparametric magnetic resonance imaging, spectroscopy and multinuclear (²³Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancer.
Academic radiology 2010;17(12):1477-85.
2010: Yuan Yao; Angela Brodie; Nancy E Davidson; Thomas W Kensler; Qun Zhou
Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer.
Breast cancer research and treatment 2010;124(2):585-91.
2010: Edith A Perez; Monica M Reinholz; David W Hillman; Kathleen S Tenner; Matthew J Schroeder; Nancy E Davidson; Silvana Martino; George W Sledge; Lyndsay N Harris; Julie R Gralow; Amylou Dueck; Rhett P Ketterling; James N Ingle; Wilma L Lingle; Peter A Kaufman; Daniel W Visscher; Robert B Jenkins
HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(28):4307-15.
2010: Steffi Oesterreich; Adrian V Lee; Nancy E Davidson
Is it time to ReSET the standard for estrogen receptor testing in breast cancer?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(27):4101-3.
2010: Harold J Burstein; Ann Alexis Prestrud; Jerome Seidenfeld; Holly Anderson; Thomas A Buchholz; Nancy E Davidson; Karen E Gelmon; Sharon H Giordano; Clifford Hudis; Jennifer Malin; Eleftherios P Mamounas; Diana Rowden; Alexander J Solky; MaryFran Sowers; Vered Stearns; Eric P Winer; Mark R Somerfield; Jennifer J Griggs
American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(23):3784-96.
2010: Antonio C Wolff; Molin Wang; Hailun Li; Michael R Pins; Florence J Pretorius; Kendrith M Rowland; Joseph A Sparano; Nancy E Davidson
Phase II trial of pegylated liposomal doxorubicin plus docetaxel with and without trastuzumab in metastatic breast cancer: Eastern Cooperative Oncology Group trial E3198.
Breast cancer research and treatment 2010;121(1):111-20.
2010: Allison Pledgie-Tracy; Madhavi Billam; Amy Hacker; Michele D Sobolewski; Patrick M Woster; Zhe Zhang; Robert A Casero; Nancy E Davidson
The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.
Cancer chemotherapy and pharmacology 2010;65(6):1067-81.
2010: Madhavi Billam; Michele D Sobolewski; Nancy E Davidson
Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells.
Breast cancer research and treatment 2010;120(3):581-92.
2010: Jennifer King; Theodore S Lawrence; Sharon B Murphy; Nancy E Davidson; Robert J Mayer
The American Society of Clinical Oncology Cancer Foundation Grants Program: a 25-year report and a look toward the future.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(9):1616-21.
2010: Qun Zhou; Raghothama Chaerkady; Patrick G Shaw; Thomas W Kensler; Akhilesh Pandey; Nancy E Davidson
Screening for therapeutic targets of vorinostat by SILAC-based proteomic analysis in human breast cancer cells.
Proteomics 2010;10(5):1029-39.
2010: Yuan Yao; Hongzhe Li; Yansong Gu; Nancy E Davidson; Qun Zhou
Inhibition of SIRT1 deacetylase suppresses estrogen receptor signaling.
Carcinogenesis 2010;31(3):382-7.
2010: Priya Rastogi; Nancy E Davidson
Trastuzumab as single agent therapy for HER2-positive metastatic breast cancer.
Onkologie 2010;33(8-9):420-1.
2010: Kathy S Albain; William E Barlow; Steven Shak; Gabriel N Hortobagyi; Robert B Livingston; I-Tien Yeh; Peter M Ravdin; Roberto Bugarini; Frederick L Baehner; Nancy E Davidson; George W Sledge; Eric P Winer; Clifford Hudis; James N Ingle; Edith A Perez; Kathleen I Pritchard; Lois Shepherd; Julie R Gralow; Carl Yoshizawa; D Craig Allred; C Kent Osborne; Daniel F Hayes
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.
The lancet oncology 2010;11(1):55-65.
2009: Leisha A Emens; Justin M Asquith; James M Leatherman; BARRY KOBRIN; Silvia Petrik; Marina Laiko; Joy Levi; Maithili M Daphtary; Barbara A Biedrzycki; Antonio C Wolff; Vered Stearns; Mary L Disis; Xiaobu Ye; Steven Piantadosi; John H Fetting; Nancy E Davidson; Elizabeth M Jaffee
Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(35):5911-8.
2009: Lorie L Hughes; Molin Wang; David L Page; Robert Gray; Lawrence J Solin; Nancy E Davidson; Mary Ann Lowen; James N Ingle; Abram Recht; William C Wood
Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(32):5319-24.
2009: Shannon Puhalla; Adam Brufsky; Nancy E Davidson
Adjuvant endocrine therapy for premenopausal women with breast cancer.
Breast (Edinburgh, Scotland) 2009;18 Suppl 3():S122-30.
2009: Qun Zhou; Patrick G Shaw; Nancy E Davidson
Inhibition of histone deacetylase suppresses EGF signaling pathways by destabilizing EGFR mRNA in ER-negative human breast cancer cells.
Breast cancer research and treatment 2009;117(2):443-51.
2009: Ani Balmanoukian; Zhe Zhang; Stacie Jeter; Shannon Slater; Deborah K Armstrong; Leisha A Emens; John H Fetting; Antonio C Wolff; Nancy E Davidson; LISA JACOBS; Julie R Lange; Theodore Tsangaris; RICHARD ZELLARS; Edward Gabrielson; Vered Stearns
African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(22):e35-7; author reply e38-9.
2009: RICHARD ZELLARS; Vered Stearns; Deborah A Frassica; Fariba Asrari; Theodore Tsangaris; Lee Myers; Shirley DiPasquale; Julie R Lange; LISA JACOBS; Leisha A Emens; Deborah K Armstrong; John H Fetting; Elizabeth Garrett-Mayer; Nancy E Davidson; Antonio C Wolff
Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(17):2816-22.
2009: Michele Y Halyard; Thomas M Pisansky; Amylou Dueck; Vera Suman; Lori J Pierce; Larry Solin; Larry Marks; Nancy E Davidson; Silvana Martino; Peter Kaufman; Leila Kutteh; Shaker R Dakhil; Edith A Perez
Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(16):2638-44.
2009: Qun Zhou; Patrick G Shaw; Nancy E Davidson
Epigenetics meets estrogen receptor: regulation of estrogen receptor by direct lysine methylation.
Endocrine-related cancer 2009;16(2):319-23.
2009: Mamatha Chivukula; Adam Brufsky; Nancy E Davidson
Small beginnings: do they matter? The importance of lymphovascular invasion in early breast cancer.
Journal of the National Cancer Institute 2009;101(10):698-9.
2009: Igal Madar; Yi Huang; Hayden T Ravert; Susan L Dalrymple; Nancy E Davidson; John T Isaacs; Robert F Dannals; J James Frost
Detection and quantification of the evolution dynamics of apoptosis using the PET voltage sensor 18F-fluorobenzyl triphenyl phosphonium.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(5):774-80.
2009: Madhavi Billam; Abigail E Witt; Nancy E Davidson
The silent estrogen receptor--can we make it speak?
Cancer biology & therapy 2009;8(6):485-96.
2009: Hetty Carraway; Shelun Wang; Amanda Blackford; Mingzhou Guo; Penny Powers; Stacie Jeter; Nancy E Davidson; Pedram Argani; Kyle Terrell; James G Herman; Julie R Lange
Promoter hypermethylation in sentinel lymph nodes as a marker for breast cancer recurrence.
Breast cancer research and treatment 2009;114(2):315-25.
2009: Shabana Shabbeer; Michelle Sobolewski; RAVI ANCHOORI; Sushant Kachhap; Manuel Hidalgo; Antonio Jimeno; Nancy E Davidson; Michael A Carducci; Saeed R Khan
Fenugreek: a naturally occurring edible spice as an anticancer agent.
Cancer biology & therapy 2009;8(3):272-8.
2009: Leisha A Emens; Nancy E Davidson
Postoperative endocrine therapy for invasive breast cancer.
Cancer treatment and research 2009;151():139-61.
2009: Michaela J Higgins; Nancy E Davidson
What is the current status of ovarian suppression/ablation in women with premenopausal early-stage breast cancer?
Current oncology reports 2009;11(1):45-50.
2008: Jane M Fall-Dickson; Victoria Mock; Ronald A Berk; Patricia M Grimm; Nancy E Davidson; Fannie Gaston-Johansson
Stomatitis-related pain in women with breast cancer undergoing autologous hematopoietic stem cell transplant.
Cancer nursing 2008;31(6):452-61.
2008: Carlos L Arteaga; Anne O'Neill; Stacy L Moulder; Michael Pins; Joseph A Sparano; George W Sledge; Nancy E Davidson
A phase I-II study of combined blockade of the ErbB receptor network with trastuzumab and gefitinib in patients with HER2 (ErbB2)-overexpressing metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(19):6277-83.
2008: Bryan P Schneider; Molin Wang; Milan Radovich; George W Sledge; Sunil Badve; Ann Thor; David A Flockhart; Bradley Hancock; Nancy E Davidson; Julie Gralow; Maura Dickler; Edith A Perez; Melody Cobleigh; Tamara Shenkier; Sara Edgerton; Kathy D Miller
Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(28):4672-8.
2008: Lori J Goldstein; Robert Gray; Sunil Badve; Barrett H Childs; Carl Yoshizawa; Steve Rowley; Steven Shak; Frederick L Baehner; Peter M Ravdin; Nancy E Davidson; George W Sledge; Edith A Perez; Lawrence N Shulman; Silvana Martino; Joseph A Sparano
Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(25):4063-71.
2008: Lori J Goldstein; Anne O'Neill; Joseph A Sparano; Edith A Perez; Lawrence N Shulman; Silvana Martino; Nancy E Davidson
Concurrent doxorubicin plus docetaxel is not more effective than concurrent doxorubicin plus cyclophosphamide in operable breast cancer with 0 to 3 positive axillary nodes: North American Breast Cancer Intergroup Trial E 2197.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(25):4092-9.
2008: Sunil S Badve; Frederick L Baehner; Robert P Gray; Barrett H Childs; Tara Maddala; Mei-Lan Liu; Steve C Rowley; Steven Shak; Edith A Perez; Edith D Perez; Lawrence J Shulman; Silvana Martino; Nancy E Davidson; George W Sledge; Lori J Goldstein; Joseph A Sparano
Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(15):2473-81.
2008: Nancy E Davidson
Tracking 35 years of progress against breast cancer.
Oncology (Williston Park, N.Y.) 2008;22(6):593-5.
2008: Qun Zhou; Agoston T Agoston; Peter Atadja; William G Nelson; Nancy E Davidson
Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cells.
Molecular cancer research : MCR 2008;6(5):873-83.
2008: James N Ingle; Dongsheng Tu; Joseph L Pater; Hyman Muss; Silvana Martino; Nicholas J Robert; Martine J Piccart; M Castiglione; Lois E Shepherd; Kathleen I Pritchard; Robert B Livingston; Nancy E Davidson; Larry Norton; Edith A Perez; Jeffrey S Abrams; David A Cameron; Michael J Palmer; Paul E Goss
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(5):877-82.
2008: Paul E Goss; James N Ingle; Joseph L Pater; Silvana Martino; Nicholas J Robert; Hyman Muss; Martine J Piccart; Monica Castiglione; Lois E Shepherd; Kathleen I Pritchard; Robert B Livingston; Nancy E Davidson; Larry Norton; Edith A Perez; Jeffrey S Abrams; David A Cameron; Michael J Palmer; Dongsheng Tu
Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(12):1948-55.
2008: Joseph A Sparano; Molin Wang; Silvana Martino; Vicky Jones; Edith A Perez; Tom Saphner; Antonio C Wolff; George W Sledge; William C Wood; Nancy E Davidson
Weekly paclitaxel in the adjuvant treatment of breast cancer.
The New England journal of medicine 2008;358(16):1663-71.
2008: Julie M Wu; Mary Jo Fackler; Marc K Halushka; Diana Molavi; M Evangeline Taylor; Wei Wen Teo; Constance A Griffin; John H Fetting; Nancy E Davidson; Angelo M DeMarzo; Jessica L Hicks; Dhananjay Chitale; Marc Ladanyi; Saraswati Sukumar; Pedram Argani
Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(7):1938-46.
2008: Nancy E Davidson
Martin D. Abeloff, MD.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(10):1573-4.
2008: Edith A Perez; Vera J Suman; Nancy E Davidson; George W Sledge; Peter A Kaufman; Clifford Hudis; Silvana Martino; Julie R Gralow; Shaker R Dakhil; James N Ingle; Eric P Winer; Karen Gelmon; Bernard J Gersh; Allan S Jaffe; Richard J Rodeheffer
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(8):1231-8.
2008: Julie R Gralow; Robert F Ozols; Dean F Bajorin; Bruce D Cheson; Howard M Sandler; Eric P Winer; James Bonner; George D Demetri; Walter Curran; Patricia Anne Ganz; Barnett S Kramer; Mark G Kris; Maurie Markman; Robert J Mayer; Derek Raghavan; Scott Ramsey; Gregory H Reaman; Raymond Sawaya; Lynn Schuchter; John W Sweetenham; Linda Vahdat; Nancy E Davidson; Richard L Schilsky; Allen S Lichter
Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):313-25.
2008: Ting Bao; Nancy E Davidson
Gene expression profiling of breast cancer.
Advances in surgery 2008;42():249-60.
2007: Kathy D Miller; Molin Wang; Julie R Gralow; Maura Dickler; Melody A Cobleigh; Edith A Perez; Tamara N Shenkier; David Cella; Nancy E Davidson
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.
The New England journal of medicine 2007;357(26):2666-76.
2007: Vered Stearns; Qun Zhou; Nancy E Davidson
Epigenetic regulation as a new target for breast cancer therapy.
Cancer investigation 2007;25(8):659-65.
2007: Ting Bao; Nancy E Davidson
How we maintain bone health in early-stage breast cancer patients on aromatase inhibitors.
Journal of oncology practice / American Society of Clinical Oncology 2007;3(6):323-5.
2007: Ben Ho Park; Nancy E Davidson
PI3 kinase activation and response to Trastuzumab Therapy: what's neu with herceptin resistance?
Cancer cell 2007;12(4):297-9.
2007: Susanne Briest; Nancy E Davidson
Aromatase inhibitors for breast cancer.
Reviews in endocrine & metabolic disorders 2007;8(3):215-28.
2007: Brian S Cornblatt; Lingxiang Ye; Albena T Dinkova-Kostova; Melanie Erb; Jed W Fahey; Navin Singh; Min-Shue A Chen; TRACEY SMITH STIERER; Elizabeth Garrett-Mayer; Pedram Argani; Nancy E Davidson; Paul Talalay; Thomas W Kensler; Kala Visvanathan
Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast.
Carcinogenesis 2007;28(7):1485-90.
2007: Meihua Sui; Yi Huang; Ben Ho Park; Nancy E Davidson; Weimin Fan
Estrogen receptor alpha mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death.
Cancer research 2007;67(11):5337-44.
2007: Nancy E Davidson
The maturation of medical oncology.
The lancet oncology 2007;8(6):457-8.
2007: Paul E Goss; James N Ingle; Silvana Martino; Nicholas J Robert; Hyman Muss; Martine J Piccart; Monica Castiglione; Dongsheng Tu; Lois E Shepherd; Kathleen I Pritchard; Robert B Livingston; Nancy E Davidson; Larry Norton; Edith A Perez; Jeffrey S Abrams; David A Cameron; Michael J Palmer; Joseph L Pater
Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2006-11.
2007: Jack Cuzick; L Ambroisine; Nancy E Davidson; R Jakesz; M Kaufmann; M Regan; R Sainsbury
Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials.
Lancet 2007;369(9574):1711-23.
2007: Kala Visvanathan; D Santor; Syed Z Ali; A Brewster; ALLYN ARNOLD; Deborah K Armstrong; Nancy E Davidson; Kathy J Helzlsouer
The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer--a potential tool for breast cancer risk assessment and biomarker evaluation.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(5):950-5.
2007: Allison Pledgie-Tracy; Michele D Sobolewski; Nancy E Davidson
Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines.
Molecular cancer therapeutics 2007;6(3):1013-21.
2007: Ting Bao; Nancy E Davidson
Adjuvant endocrine therapy for premenopausal women with early breast cancer.
Breast cancer research : BCR 2007;9(6):115.
2007: Justin Stebbing; Vered Stearns; Nancy E Davidson
Role of CYP2D6 testing in selection of endocrine therapy for breast cancer.
Pharmacogenomics 2007;8(1):1-3.
2007: Qun Zhou; Peter Atadja; Nancy E Davidson
Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation.
Cancer biology & therapy 2007;6(1):64-9.
2006: Kala Visvanathan; Deborah Santor; Syed Z Ali; In Soon Hong; Nancy E Davidson; Kathy J Helzlsouer
The importance of cytologic intrarater and interrater reproducibility: the case of ductal lavage.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(12):2553-6.
2006: Regina J Brown; Nancy E Davidson
Adjuvant hormonal therapy for premenopausal women with breast cancer.
Seminars in oncology 2006;33(6):657-63.
2006: Kala Visvanathan; Saraswati Sukumar; Nancy E Davidson
Epigenetic biomarkers and breast cancer: cause for optimism.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(22):6591-3.
2006: Robert W Carlson; Anne M O'Neill; Lori J Goldstein; Branimir I Sikic; Neil Abramson; James A Stewart; Nancy E Davidson; William C Wood
A pilot phase II trial of valspodar modulation of multidrug resistance to paclitaxel in the treatment of metastatic carcinoma of the breast (E1195): a trial of the Eastern Cooperative Oncology Group.
Cancer investigation 2006;24(7):677-81.
2006: Antonio C Wolff; Nancy E Davidson
Still waiting after 110 years: the optimal use of ovarian ablation as adjuvant therapy for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(31):4949-51.
2006: James Khatcheressian; Antonio C Wolff; Thomas J Smith; Eva Grunfeld; Hyman Muss; Victor Vogel; Francine Halberg; Mark R Somerfield; Nancy E Davidson
American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(31):5091-7.
2006: James N Ingle; Dongsheng Tu; Joseph L Pater; Silvana Martino; Nicholas J Robert; Hyman Muss; Martine J Piccart; Monica Castiglione; Lois E Shepherd; Kathleen I Pritchard; Robert B Livingston; Nancy E Davidson; Larry Norton; Edith A Perez; Jeffrey S Abrams; David A Cameron; Michael J Palmer; Paul E Goss
Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial.
Breast cancer research and treatment 2006;99(3):295-300.
2006: Abde M Abukhdeir; Brian G Blair; Keith Brenner; Bedri Karakas; HIROYUKI KONISHI; Joselin Lim; Vanita Sahasranaman; Yi Huang; Judith Keen; Nancy E Davidson; Michele Vitolo; Kurtis E Bachman; Ben Ho Park
Physiologic estrogen receptor alpha signaling in non-tumorigenic human mammary epithelial cells.
Breast cancer research and treatment 2006;99(1):23-33.
2006: Yi Huang; Judith C Keen; Allison Pledgie; Laurence J Marton; Tao Zhu; Saraswati Sukumar; Ben Ho Park; Brian G Blair; Keith Brenner; Robert A Casero; Nancy E Davidson
Polyamine analogues down-regulate estrogen receptor alpha expression in human breast cancer cells.
The Journal of biological chemistry 2006;281(28):19055-63.
2006: Qun Zhou; Nancy E Davidson
Silencing estrogen receptor alpha in breast cancer cells.
Cancer biology & therapy 2006;5(7):848-9.
2006: Edith A Perez; Vera J Suman; Nancy E Davidson; Silvana Martino; Peter A Kaufman; Wilma L Lingle; Patrick J Flynn; James N Ingle; Daniel W Visscher; Robert B Jenkins
HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3032-8.
2006: Dipali Sharma; Neeraj Saxena; Nancy E Davidson; Paula M Vertino
Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes.
Cancer research 2006;66(12):6370-8.
2006: Mary Jo Fackler; Kara Malone; Zhe Zhang; Eric Schilling; Elizabeth Garrett-Mayer; Theresa Swift-Scanlan; Julie R Lange; Ritu Nayar; Nancy E Davidson; Seema A Khan; Saraswati Sukumar
Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(11 Pt 1):3306-10.
2006: Antonio C Wolff; Richard J Jones; Nancy E Davidson; Stacie C Jeter; Vered Stearns
Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy with pegfilgrastim support.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(15):2392-4; author reply 2394-5.
2006: Scott L Kominsky; Nancy E Davidson
A "bone" fide predictor of metastasis? Predicting breast cancer metastasis to bone.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(15):2227-9.
2006: Aneta Modzelewska; Catherine Pettit; Geetha Achanta; Nancy E Davidson; Peng Huang; Saeed R Khan
Anticancer activities of novel chalcone and bis-chalcone derivatives.
Bioorganic & medicinal chemistry 2006;14(10):3491-5.
2006: Stanley Zucker; Molin Wang; Joseph A Sparano; William J Gradishar; James N Ingle; Nancy E Davidson
Plasma matrix metalloproteinases 7 and 9 in patients with metastatic breast cancer treated with marimastat or placebo: Eastern Cooperative Oncology Group trial E2196.
Clinical breast cancer 2006;6(6):525-9.
2006: James D Yager; Nancy E Davidson
Estrogen carcinogenesis in breast cancer.
The New England journal of medicine 2006;354(3):270-82.
2005: Allison Pledgie; Yi Huang; Amy Hacker; Zhe Zhang; Patrick M Woster; Nancy E Davidson; Robert A Casero
Spermine oxidase SMO(PAOh1), Not N1-acetylpolyamine oxidase PAO, is the primary source of cytotoxic H2O2 in polyamine analogue-treated human breast cancer cell lines.
The Journal of biological chemistry 2005;280(48):39843-51.
2005: Jinong Li; Rosaria Orlandi; C Nicole White; Jason Rosenzweig; Jing Zhao; Ettore Seregni; Daniele Morelli; Yinhua Yu; Xiao-Ying Meng; Zhen Zhang; Nancy E Davidson; Eric T Fung; Daniel W Chan
Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry.
Clinical chemistry 2005;51(12):2229-35.
2005: Nancy E Davidson; Monica Morrow; Daniel B Kopans; Frederick C Koerner
Case records of the Massachusetts General Hospital. Case 35-2005. A 56-year-old woman with breast cancer and isolated tumor cells in a sentinel lymph node.
The New England journal of medicine 2005;353(20):2177-85.
2005: Edward Romond; Edith A Perez; John Bryant; Vera J Suman; Charles E Geyer; Nancy E Davidson; Elizabeth Tan-Chiu; Silvana Martino; Soonmyung Paik; Peter A Kaufman; Sandra M Swain; Thomas M Pisansky; Louis Fehrenbacher; Leila A Kutteh; Victor Vogel; Daniel W Visscher; Greg Yothers; Robert B Jenkins; Ann M Brown; Shaker R Dakhil; Eleftherios P Mamounas; Wilma L Lingle; Pamela M Klein; James N Ingle; Norman Wolmark
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
The New England journal of medicine 2005;353(16):1673-84.
2005: Antonio C Wolff; Anne O'Neill; M John Kennedy; James A Stewart; William J Gradishar; Raymond S Lord; Nancy E Davidson; William C Wood
Single-agent topotecan as first-line chemotherapy in women with metastatic breast cancer: final results of eastern cooperative oncology group trial E8193.
Clinical breast cancer 2005;6(4):334-9.
2005: Paul E Goss; James N Ingle; Silvana Martino; Nicholas J Robert; Hyman Muss; Martine J Piccart; Monica Castiglione; Dongsheng Tu; Lois E Shepherd; Kathleen I Pritchard; Robert B Livingston; Nancy E Davidson; Larry Norton; Edith A Perez; Jeffrey S Abrams; David A Cameron; Michael J Palmer; Joseph L Pater
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.
Journal of the National Cancer Institute 2005;97(17):1262-71.
2005: Nancy E Davidson; Saraswati Sukumar
Of Snail, mice, and women.
Cancer cell 2005;8(3):173-4.
2005: Yi Huang; Allison Pledgie; Ethel Rubin; Laurence J Marton; Patrick M Woster; Saraswati Sukumar; Robert A Casero; Nancy E Davidson
Role of p53/p21(Waf1/Cip1) in the regulation of polyamine analogue-induced growth inhibition and cell death in human breast cancer cells.
Cancer biology & therapy 2005;4(9):1006-13.
2005: Nancy E Davidson; Anne M O'Neill; Allen M Vukov; C Kent Osborne; Silvana Martino; Douglas R White; Martin D Abeloff
Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(25):5973-82.
2005: Judith C Keen; Qun Zhou; Ben Ho Park; Catherine Pettit; Kelly M Mack; Brian G Blair; Keith Brenner; Nancy E Davidson
Protein phosphatase 2A regulates estrogen receptor alpha (ER) expression through modulation of ER mRNA stability.
The Journal of biological chemistry 2005;280(33):29519-24.
2005: Dipali Sharma; Julie Blum; Xiaowei Yang; Normand Beaulieu; A Robert MacLeod; Nancy E Davidson
Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells.
Molecular endocrinology (Baltimore, Md.) 2005;19(7):1740-51.
2005: Victoria Mock; Constantine E Frangakis; Nancy E Davidson; Mary E Ropka; Mary Pickett; Barbara Poniatowski; Kerry Stewart; Lane Cameron; Kristin L Zawacki; Laura J Podewils; GARY COHEN; Ruth McCorkle
Exercise manages fatigue during breast cancer treatment: a randomized controlled trial.
Psycho-oncology 2005;14(6):464-77.
2005: Agoston T Agoston; Pedram Argani; Srinivasan Yegnasubramanian; Angelo M DeMarzo; Mohammad Ali Ansari-Lari; Jessica L Hicks; Nancy E Davidson; William G Nelson
Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancer.
The Journal of biological chemistry 2005;280(18):18302-10.
2005: Yi Huang; Allison Pledgie; Robert A Casero; Nancy E Davidson
Molecular mechanisms of polyamine analogs in cancer cells.
Anti-cancer drugs 2005;16(3):229-41.
2005: Nancy E Davidson; Monica Morrow
Sometimes a great notion--an assessment of neoadjuvant systemic therapy for breast cancer.
Journal of the National Cancer Institute 2005;97(3):159-61.
2005: JANICE DAVIS SPROUL; M P Harris; Nancy E Davidson; BARRY KOBRIN; Elizabeth M Jaffee; Leisha A Emens
Cost-effective manufacture of an allogeneic GM-CSF-secreting breast tumor vaccine in an academic cGMP facility.
Cytotherapy 2005;7(1):46-56.
2004: Judith C Keen; Elizabeth Garrett-Mayer; Catherine Pettit; Kelly M Mack; Jasper Manning; James G Herman; Nancy E Davidson
Epigenetic regulation of protein phosphatase 2A (PP2A), lymphotactin (XCL1) and estrogen receptor alpha (ER) expression in human breast cancer cells.
Cancer biology & therapy 2004;3(12):1304-12.
2004: Joseph A Sparano; Patricia Bernardo; Patricia Stephenson; William J Gradishar; James N Ingle; Stanley Zucker; Nancy E Davidson
Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(23):4683-90.
2004: Michael A Jacobs; Ronald Ouwerkerk; Antonio C Wolff; Vered Stearns; Paul A Bottomley; Peter B Barker; Pedram Argani; NAGI KHOURI; Nancy E Davidson; Zaver M Bhujwalla; David A Bluemke
Multiparametric and multinuclear magnetic resonance imaging of human breast cancer: current applications.
Technology in cancer research & treatment 2004;3(6):543-50.
2004: Edith A Perez; Vera J Suman; Nancy E Davidson; Peter A Kaufman; Silvana Martino; Shaker R Dakhil; James N Ingle; Richard J Rodeheffer; Bernard J Gersh; Allan S Jaffe
Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(18):3700-4.
2004: Leisha A Emens; Nancy E Davidson
Trastuzumab in breast cancer.
Oncology (Williston Park, N.Y.) 2004;18(9):1117-28; discussion 1131-2, 1137-8.
2004: Edward Gabrielson; Ellen Tully; Amy Hacker; Anthony E Pegg; Nancy E Davidson; Robert A Casero
Induction of spermidine/spermine N1-acetyltransferase in breast cancer tissues treated with the polyamine analogue N1, N11-diethylnorspermine.
Cancer chemotherapy and pharmacology 2004;54(2):122-6.
2004: Ben Ho Park; Nancy E Davidson
Estrogen receptor status, cell cycling and paclitaxel: looking for a "hormone"-ious explanation.
Cancer biology & therapy 2004;3(5):468-9.
2004: Vered Stearns; Nancy E Davidson
Déjà vu for breast cancer two?
Journal of the National Cancer Institute 2004;96(7):497-9.
2004: Leisha A Emens; Deborah K Armstrong; Barbara A Biedrzycki; Nancy E Davidson; JANICE DAVIS SPROUL; John H Fetting; Elizabeth M Jaffee; Beth Onners; Steven Piantadosi; Richard T. Reilly; Vered Stearns; Irena Tartakovsky; Kala Visvanathan; Antonio C Wolff
A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin.
Human gene therapy 2004;15(3):313-37.
2004: Yi Huang; Judith C Keen; Erin R Hager; Renee Smith; Amy Hacker; Benjamin Frydman; Aldonia Valasinas; Venudhar Reddy; Laurence J Marton; Robert A Casero; Nancy E Davidson
Regulation of polyamine analogue cytotoxicity by c-Jun in human MDA-MB-435 cancer cells.
Molecular cancer research : MCR 2004;2(2):81-8.
2004: Tatiana M Prowell; Nancy E Davidson
What is the role of ovarian ablation in the management of primary and metastatic breast cancer today?
The oncologist 2004;9(5):507-17.
2004: Vered Stearns; Nancy E Davidson; David A Flockhart
Pharmacogenetics in the treatment of breast cancer.
The pharmacogenomics journal 2004;4(3):143-53.
2003: Antonio C Wolff; Deborah K Armstrong; John H Fetting; M Katherine Carducci; Carol D Riley; John F Bender; Robert A Casero; Nancy E Davidson
A Phase II study of the polyamine analog N1,N11-diethylnorspermine (DENSpm) daily for five days every 21 days in patients with previously treated metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(16 Pt 1):5922-8.
2003: Nancy E Davidson; Kala Visvanathan; Leisha A Emens
New findings about endocrine therapy for breast cancer.
Breast (Edinburgh, Scotland) 2003;12(6):368-72.
2003: Paul E Goss; James N Ingle; Silvana Martino; Nicholas J Robert; Hyman Muss; Martine J Piccart; Monica Castiglione; Dongsheng Tu; Lois E Shepherd; Kathleen I Pritchard; Robert B Livingston; Nancy E Davidson; Larry Norton; Edith A Perez; Jeffrey S Abrams; Patrick Therasse; Michael J Palmer; Joseph L Pater
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.
The New England journal of medicine 2003;349(19):1793-802.
2003: Kangmin Zhu; Nancy E Davidson; Sandra Hunter; Xiaowei Yang; Kathleen Payne-Wilks; Chanel L Roland; Dawn Phillips; Christy Bentley; Min Dai; scott williams
Methyl-group dietary intake and risk of breast cancer among African-American women: a case-control study by methylation status of the estrogen receptor alpha genes.
Cancer causes & control : CCC 2003;14(9):827-36.
2003: Judith C Keen; Lan Yan; Kelly M Mack; Catherine Pettit; Dawn Smith; Dipali Sharma; Nancy E Davidson
A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine.
Breast cancer research and treatment 2003;81(3):177-86.
2003: Lan Yan; Sharyl J Nass; Dawn Smith; William G Nelson; James G Herman; Nancy E Davidson
Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines.
Cancer biology & therapy 2003;2(5):552-6.
2003: Srinivas K Kumar; Erin R Hager; Catherine Pettit; Hallur Gurulingappa; Nancy E Davidson; Saeed R Khan
Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents.
Journal of medicinal chemistry 2003;46(14):2813-5.
2003: Yi Huang; Erin R Hager; Dawn L Phillips; Valerie R Dunn; Amy Hacker; Benjamin Frydman; John A Kink; Aldonia Valasinas; Venudhar Reddy; Laurence J Marton; Robert A Casero; Nancy E Davidson
A novel polyamine analog inhibits growth and induces apoptosis in human breast cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(7):2769-77.
2003: Leisha A Emens; Nancy E Davidson
The follow-up of breast cancer.
Seminars in oncology 2003;30(3):338-48.
2003: Marc L Citron; Donald A Berry; Constance Cirrincione; Clifford Hudis; Eric P Winer; William J Gradishar; Nancy E Davidson; Silvana Martino; Robert Livingston; James N Ingle; Edith A Perez; John Carpenter; David D Hurd; James F Holland; Barbara L Smith; Carolyn I Sartor; Eleanor H Leung; Jeffrey Abrams; Richard L Schilsky; Hyman Muss; Larry Norton
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(8):1431-9.
2003: Kala Visvanathan; Nancy E Davidson
Aromatase inhibitors as adjuvant therapy in breast cancer.
Oncology (Williston Park, N.Y.) 2003;17(3):335-42, 347; discussion 347-50, 354.
2003: Judith C Keen; Nancy E Davidson
The biology of breast carcinoma.
Cancer 2003;97(3 Suppl):825-33.
2003: Leisha A Emens; Nancy E Davidson
Adjuvant hormonal therapy for premenopausal women with breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1 Pt 2):486S-94S.
2003: Steven E Come; Aman U Buzdar; Carlos L Arteaga; Angela Brodie; Nancy E Davidson; Mitch Dowsett; James N Ingle; Stephen R D Johnston; Adrian V Lee; C Kent Osborne; Kathleen I Pritchard; Victor G Vogel; Eric P Winer; Carol S Hart
Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: summary consensus statement.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1 Pt 2):443S-6S.
2003: Xiaowei Yang; Susan Groshen; Silvia C Formenti; Nancy E Davidson; Michael F Press
P7 antigen expression in human breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):201-6.
2002: Leisha A Emens; M John Kennedy; John H Fetting; Nancy E Davidson; Elizabeth Garrett-Mayer; Deborah K Armstrong
A phase I toxicity and feasibility trial of sequential dose-dense induction chemotherapy with doxorubicin, paclitaxel, and 5-fluorouracil followed by high dose consolidation for high-risk primary breast cancer.
Breast cancer research and treatment 2002;76(2):145-56.
2002: Nancy E Davidson
Ongoing US cooperative group trials using taxanes in the adjuvant setting.
Clinical breast cancer 2002;3 Suppl 2():S53-8.
2002: Nancy E Davidson; Kathy J Helzlsouer
Good news about oral contraceptives.
The New England journal of medicine 2002;346(26):2078-9.
2002: Patrick C Roche; Vera J Suman; Robert B Jenkins; Nancy E Davidson; Silvana Martino; Peter A Kaufman; Ferdinand K Addo; Bronagh Murphy; James N Ingle; Edith A Perez
Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831.
Journal of the National Cancer Institute 2002;94(11):855-7.
2002: Nancy E Davidson; Mark Levine
Breast cancer consensus meetings: vive la difference?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1719-20.
2002: Antonio C Wolff; Nancy E Davidson
Preoperative therapy in breast cancer: lessons from the treatment of locally advanced disease.
The oncologist 2002;7(3):239-45.
2001: Antonio C Wolff; Nancy E Davidson
Use of SERMs for the adjuvant therapy of early-stage breast cancer.
Annals of the New York Academy of Sciences 2001;949():80-8.
2001: Xiaoming Yang; D L Phillips; AT Ferguson; William G Nelson; James G Herman; Nancy E Davidson
Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells.
Cancer research 2001;61(19):7025-9.
2001: Elizabeth Dees; Nancy E Davidson
Ovarian ablation as adjuvant therapy for breast cancer.
Seminars in oncology 2001;28(4):322-31.
2001: Aman U Buzdar; J Douma; Nancy E Davidson; Richard M Elledge; M Morgan; R Smith; L Porter; Jean-Marc Nabholtz; X Xiang; C Brady
Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(14):3357-66.
2001: Xiaoming Yang; L Yan; Nancy E Davidson
DNA methylation in breast cancer.
Endocrine-related cancer 2001;8(2):115-27.
2001: Deborah K Armstrong; Nancy E Davidson
Dose intensity for breast cancer.
Oncology (Williston Park, N.Y.) 2001;15(6):701-8, 712; discussion 712-4, 717-8.
2001: Ella Evron; William C Dooley; Christopher B Umbricht; Dorothy L Rosenthal; N Sacchi; Edward Gabrielson; A B Soito; David T Hung; B Ljung; Nancy E Davidson; Saraswati Sukumar
Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR.
Lancet 2001;357(9265):1335-6.
2001: L Yan; X Yang; Nancy E Davidson
Role of DNA methylation and histone acetylation in steroid receptor expression in breast cancer.
Journal of mammary gland biology and neoplasia 2001;6(2):183-92.
2001: Hillary A Hahm; V R Dunn; KA Butash; W L Deveraux; Patrick M Woster; Robert A Casero; Nancy E Davidson
Combination of standard cytotoxic agents with polyamine analogues in the treatment of breast cancer cell lines.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(2):391-9.
2001: Deborah K Armstrong; Nancy E Davidson
Dose intensity for breast cancer: where do we go from here?
Breast disease 2001;14():91-7.
2001: Nancy E Davidson
Ovarian ablation as adjuvant therapy for breast cancer.
Journal of the National Cancer Institute. Monographs 2001;(30):67-71.
2001: Thomas W Kensler; Nancy E Davidson; John Groopman; ALVARO MUNOZ
Biomarkers and surrogacy: relevance to chemoprevention.
IARC scientific publications 2001;154():27-47.
2000: X Yang; AT Ferguson; Sharyl J Nass; D L Phillips; KA Butash; S M Wang; James G Herman; Nancy E Davidson
Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition.
Cancer research 2000;60(24):6890-4.
2000: ELSKEN VAN DER WALL; T Horn; Emilie C Bright; J L Passos-Coehlo; S Bond; B Clarke; VL Altomonte; K McIntyre; Georgia B Vogelsang; Stephen J Noga; JANICE DAVIS SPROUL; J Thomassen; KV Ohly; S M Lee; John H Fetting; Deborah K Armstrong; Nancy E Davidson; Allan Hess; M John Kennedy
Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells.
British journal of cancer 2000;83(11):1405-11.
2000: R W Carlson; Benjamin O Anderson; W Bensinger; C E Cox; Nancy E Davidson; S B Edge; W B Farrar; Lori J Goldstein; William J Gradishar; Allen S Lichter; Beryl Mc Cormick; Lisle M Nabell; Elizabeth C Reed; Samuel Michael Silver; M L Smith; G Somlo; Richard Theriault; John H Ward; Eric P Winer; Antonio C Wolff
NCCN Practice Guidelines for Breast Cancer.
Oncology (Williston Park, N.Y.) 2000;14(11A):33-49.
2000: Sharyl J Nass; James G Herman; Edward Gabrielson; Philip W Iversen; F F Parl; Nancy E Davidson; Jeremy R Graff
Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer.
Cancer research 2000;60(16):4346-8.
2000: Antonio C Wolff; Nancy E Davidson
Early operable breast cancer.
Current treatment options in oncology 2000;1(3):210-20.
2000: C Jackisch; Hillary A Hahm; Bertrand Tombal; Diane E McCloskey; KA Butash; Nancy E Davidson; Samuel R Denmeade
Delayed micromolar elevation in intracellular calcium precedes induction of apoptosis in thapsigargin-treated breast cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(7):2844-50.
2000: Nancy E Davidson
Combined endocrine therapy for breast cancer--new life for an old idea?
Journal of the National Cancer Institute 2000;92(11):859-60.
2000: Antonio C Wolff; Nancy E Davidson
Primary systemic therapy in operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(7):1558-69.
2000: Hillary A Hahm; Deborah K Armstrong; Tian Ling Chen; Louise B. Grochow; J Passos-Coelho; Steven Goodman; Nancy E Davidson; M John Kennedy
Novobiocin in combination with high-dose chemotherapy for the treatment of advanced breast cancer: a phase 2 study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(3A):335-43.
2000: Diane E McCloskey; Patrick M Woster; Robert A Casero; Nancy E Davidson
Effects of the polyamine analogues N1-ethyl-N11-((cyclopropyl)methyl)-4,8-diazaundecane and N1-ethylN-11-((cycloheptyl)methyl)-4,8-diazaundecane in human prostate cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(1):17-23.
1999: Sharyl J Nass; AT Ferguson; Dorraya El-Ashry; William G Nelson; Nancy E Davidson
Expression of DNA methyl-transferase (DMT) and the cell cycle in human breast cancer cells.
Oncogene 1999;18(52):7453-61.
1999: Antonio C Wolff; Nancy E Davidson
New data on adjuvant therapy for breast cancer.
Current oncology reports 1999;1(1):31-7.
1999: Abram Recht; R Gray; Nancy E Davidson; B L Fowble; L J Solin; F J Cummings; Geoffrey Falkson; H C Falkson; S G Taylor; Douglass C Tormey
Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(6):1689-700.
1999: Timothy J Kottke; April L Blajeski; LM Martins; Peter W Mesner; Nancy E Davidson; William C Earnshaw; Deborah K Armstrong; Scott H Kaufmann
Comparison of paclitaxel-, 5-fluoro-2'-deoxyuridine-, and epidermal growth factor (EGF)-induced apoptosis. Evidence for EGF-induced anoikis.
The Journal of biological chemistry 1999;274(22):15927-36.
1999: Sharyl J Nass; Nancy E Davidson
The biology of breast cancer.
Hematology/oncology clinics of North America 1999;13(2):311-32.
1999: Nancy E Davidson; Hillary A Hahm; Diane E McCloskey; Patrick M Woster; Robert A Casero
Clinical aspects of cell death in breast cancer: the polyamine pathway as a new target for treatment.
Endocrine-related cancer 1999;6(1):69-73.
1999: Thomas J Smith; Nancy E Davidson; D V Schapira; E Grunfeld; Hyman Muss; V G Vogel; Mark R Somerfield
American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):1080-2.
1999: Bahar Mikhak; Marianna Zahurak; MD Abeloff; John H Fetting; Nancy E Davidson; Ross C Donehower; W Waterfield; M John Kennedy
Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinoma.
Cancer 1999;85(4):899-904.
1999: S Subramanyan; MD Abeloff; S E Bond; Nancy E Davidson; John H Fetting; G B Gordon; M John Kennedy
A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer.
Cancer chemotherapy and pharmacology 1999;43(6):497-502.
1998: Nancy E Davidson
Environmental estrogens and breast cancer risk.
Current opinion in oncology 1998;10(5):475-8.
1998: AT Ferguson; Rena Lapidus; Nancy E Davidson
Demethylation of the progesterone receptor CpG island is not required for progesterone receptor gene expression.
Oncogene 1998;17(5):577-83.
1998: Sharyl J Nass; Hillary A Hahm; Nancy E Davidson
Breast cancer biology blossoms in the clinic.
Nature medicine 1998;4(7):761-2.
1998: Rena Lapidus; Sharyl J Nass; KA Butash; F F Parl; Sigmund A Weitzman; J G Graff; James G Herman; Nancy E Davidson
Mapping of ER gene CpG island methylation-specific polymerase chain reaction.
Cancer research 1998;58(12):2515-9.
1998: Hillary A Hahm; Nancy E Davidson; J K Giguere; Cathy DiBernardo; S O'Reilly
Breast cancer metastatic to the choroid.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2280-2.
1998: Thomas W Kensler; Xia He; MA Otieno; Patricia A Egner; Lisa P Jacobson; B Chen; Jia-Sheng Wang; Yuan-Rong Zhu; Bao-Chu Zhang; Jin-Bing Wang; Yan Wu; Qi-Nan Zhang; Geng-Sun Qian; Shuang-Yuan Kuang; X Fang; YF Li; LY Yu; HJ Prochaska; Nancy E Davidson; GB Gordon; MB Gorman; A Zarba; CL Enger; ALVARO MUNOZ; Kathy J Helzlsouer
Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1998;7(2):127-34.
1998: Rena Lapidus; Sharyl J Nass; Nancy E Davidson
The loss of estrogen and progesterone receptor gene expression in human breast cancer.
Journal of mammary gland biology and neoplasia 1998;3(1):85-94.
1998: AT Ferguson; Rena Lapidus; Nancy E Davidson
The regulation of estrogen receptor expression and function in human breast cancer.
Cancer treatment and research 1998;94():255-78.
1997: AT Ferguson; Paula M Vertino; Jeff Spitzner; Stephen B Baylin; Mark T Muller; Nancy E Davidson
Role of estrogen receptor gene demethylation and DNA methyltransferase.DNA adduct formation in 5-aza-2'deoxycytidine-induced cytotoxicity in human breast cancer cells.
The Journal of biological chemistry 1997;272(51):32260-6.
1997: Nancy E Davidson; James D Yager
Pesticides and breast cancer: fact or fad?
Journal of the National Cancer Institute 1997;89(23):1743-4.
1997: Lisa P Jacobson; Bao-Chu Zhang; Yuan-Rong Zhu; Jin-Bing Wang; Yan Wu; Qi-Nan Zhang; LY Yu; Geng-Sun Qian; Shuang-Yuan Kuang; YF Li; X Fang; A Zarba; B Chen; CL Enger; Nancy E Davidson; MB Gorman; GB Gordon; HJ Prochaska; Patricia A Egner; John Groopman; ALVARO MUNOZ; Kathy J Helzlsouer; Thomas W Kensler
Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1997;6(4):257-65.
1997: Bao-Chu Zhang; Yuan-Rong Zhu; Jin-Bing Wang; Yan Wu; Qi-Nan Zhang; Geng-Sun Qian; Shuang-Yuan Kuang; YF Li; X Fang; LY Yu; Silvio De Flora; Lisa P Jacobson; A Zarba; Patricia A Egner; Xia He; Jia-Sheng Wang; B Chen; CL Enger; Nancy E Davidson; GB Gordon; MB Gorman; HJ Prochaska; John Groopman; ALVARO MUNOZ; Thomas W Kensler
Oltipraz chemoprevention trial in Qidong, Jiangsu Province, People's Republic of China.
Journal of cellular biochemistry. Supplement 1997;28-29():166-73.
1997: AT Ferguson; Nancy E Davidson
Regulation of estrogen receptor alpha function in breast cancer.
Critical reviews in oncogenesis 1997;8(1):29-46.
1997: Samuel R Denmeade; Diane E McCloskey; IB Joseph; Hillary A Hahm; John T Isaacs; Nancy E Davidson
Apoptosis in hormone-responsive malignancies.
Advances in pharmacology (San Diego, Calif.) 1997;41():553-83.
1996: A A Ross; T J Layton; A B Ostrander; J L Passos-Coelho; JANICE DAVIS SPROUL; A M Huelskamp; Stephen J Noga; Nancy E Davidson; M J Kennedy; Brenda W Cooper; Stanton L Gerson; Hillard M Lazarus; K Holland; Stefan Gluck; T J Moss; A Kaubish; Linda Vahdat; K Antman
Comparative analysis of breast cancer contamination in mobilized and nonmobilized hematopoietic grafts.
Journal of hematotherapy 1996;5(5):549-52.
1996: J L Passos-Coelho; A A Ross; D J Kahn; T J Moss; JANICE DAVIS SPROUL; A M Huelskamp; Stephen J Noga; Nancy E Davidson; M J Kennedy
Similar breast cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(9):2569-75.
1996: Nancy E Davidson
Is hormone replacement therapy a risk?
Scientific American 1996;275(3):101.
1996: Ellen S Pizer; C Jackisch; F D Wood; Gary R Pasternack; Nancy E Davidson; Francis P Kuhajda
Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells.
Cancer research 1996;56(12):2745-7.
1996: Diane E McCloskey; Scott H Kaufmann; L J Prestigiacomo; Nancy E Davidson
Paclitaxel induces programmed cell death in MDA-MB-468 human breast cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(5):847-54.
1996: Rena Lapidus; AT Ferguson; YVONNE OTTAVIANO; F F Parl; H S Smith; S A Weitzman; Stephen B Baylin; Jean-Pierre J Issa; Nancy E Davidson
Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(5):805-10.
1996: Diane E McCloskey; J Yang; Patrick M Woster; Nancy E Davidson; Robert A Casero
Polyamine analogue induction of programmed cell death in human lung tumor cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(3):441-6.
1996: Jean-Pierre J Issa; B A Zehnbauer; Curt I Civin; Michael I Collector; Saul J Sharkis; Nancy E Davidson; Scott H Kaufmann; Stephen B Baylin
The estrogen receptor CpG island is methylated in most hematopoietic neoplasms.
Cancer research 1996;56(5):973-77.
1996: Nancy E Davidson; M J Kennedy
Protein kinase C and breast cancer.
Cancer treatment and research 1996;83():91-105.
1996: Diane E McCloskey; Deborah K Armstrong; C Jackisch; Nancy E Davidson
Programmed cell death in human breast cancer cells.
Recent progress in hormone research 1996;51():493-508.
1995: Jeremy R Graff; James G Herman; Rena Lapidus; H Chopra; R Xu; David F Jarrard; William B Isaacs; PAULA PITHA-ROWE; Nancy E Davidson; Stephen B Baylin
E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.
Cancer research 1995;55(22):5195-9.
1995: James G Herman; A Merlo; Li Mao; Rena Lapidus; Jean-Pierre J Issa; Nancy E Davidson; David Sidransky; Stephen B Baylin
Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.
Cancer research 1995;55(20):4525-30.
1995: Richard M Elledge; R Gray; E Mansour; Y Yu; Gary M Clark; Peter M Ravdin; C Kent Osborne; K Gilchrist; Nancy E Davidson; N Robert
Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer.
Journal of the National Cancer Institute 1995;87(16):1254-6.
1995: Diane E McCloskey; Robert A Casero; Patrick M Woster; Nancy E Davidson
Induction of programmed cell death in human breast cancer cells by an unsymmetrically alkylated polyamine analogue.
Cancer research 1995;55(15):3233-6.
1995: Nancy E Davidson
Hormone-replacement therapy--breast versus heart versus bone.
The New England journal of medicine 1995;332(24):1638-9.
1995: AT Ferguson; Rena Lapidus; Stephen B Baylin; Nancy E Davidson
Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression.
Cancer research 1995;55(11):2279-83.
1995: M J Kennedy; Deborah K Armstrong; A M Huelskamp; K Ohly; B V Clarke; O Michael Colvin; Louise B. Grochow; Tian Ling Chen; Nancy E Davidson
Phase I and pharmacologic study of the alkylating agent modulator novobiocin in combination with high-dose chemotherapy for the treatment of metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1136-43.
1995: J L Passos-Coelho; Hayden Braine; JANICE DAVIS SPROUL; A M Huelskamp; K G Schepers; K Ohly; B Clarke; S K Wright; Stephen J Noga; Nancy E Davidson
Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(3):705-14.
1995: J L Passos-Coelho; A A Ross; T J Moss; JANICE DAVIS SPROUL; A M Huelskamp; Stephen J Noga; Nancy E Davidson; M J Kennedy
Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte-macrophage colony-stimulating factor.
Blood 1995;85(4):1138-43.
1994: W S May; P G Tyler; T Ito; Deborah K Armstrong; K A Qatsha; Nancy E Davidson
Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2 alpha in association with suppression of apoptosis.
The Journal of biological chemistry 1994;269(43):26865-70.
1994: Deborah K Armstrong; Scott H Kaufmann; YVONNE OTTAVIANO; Y Furuya; J A Buckley; John T Isaacs; Nancy E Davidson
Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells.
Cancer research 1994;54(20):5280-3.
1994: Melody A Cobleigh; R F Berris; T Bush; Nancy E Davidson; N J Robert; Joseph A Sparano; D C Tormey; W C Wood
Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology Group.
JAMA : the journal of the American Medical Association 1994;272(7):540-5.
1994: Jean-Pierre J Issa; YVONNE OTTAVIANO; P Celano; Stanley R Hamilton; Nancy E Davidson; Stephen B Baylin
Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon.
Nature genetics 1994;7(4):536-40.
1994: YVONNE OTTAVIANO; Jean-Pierre J Issa; F F Parl; H S Smith; Stephen B Baylin; Nancy E Davidson
Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells.
Cancer research 1994;54(10):2552-5.
1994: J Passos-Coelho; A A Ross; JANICE DAVIS SPROUL; A M Huelskamp; B Clarke; Stephen J Noga; Nancy E Davidson; M J Kennedy
Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: effect of ex vivo purging with 4-hydroperoxycyclophosphamide.
Cancer research 1994;54(9):2366-71.
1994: M J Kennedy; Georgia B Vogelsang; Richard J Jones; Evan Farmer; Allan Hess; VL Altomonte; A M Huelskamp; Nancy E Davidson
Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(2):249-57.
1994: Nancy E Davidson; M D Abeloff
Adjuvant therapy of breast cancer.
World journal of surgery 1994;18(1):112-6.
1994: Nancy E Davidson
Ovarian ablation as treatment for young women with breast cancer.
Journal of the National Cancer Institute. Monographs 1994;(16):95-9.
1993: Deborah K Armstrong; John H Fetting; Nancy E Davidson; G B Gordon; A M Huelskamp; M D Abeloff
Sixteen week dose intense chemotherapy for inoperable, locally advanced breast cancer.
Breast cancer research and treatment 1993;28(3):277-84.
1993: M J Kennedy; JANICE DAVIS SPROUL; J Passos-Coelho; Stephen J Noga; A M Huelskamp; K Ohly; Nancy E Davidson
Administration of human recombinant granulocyte colony-stimulating factor (filgrastim) accelerates granulocyte recovery following high-dose chemotherapy and autologous marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow in women with metastatic breast cancer.
Cancer research 1993;53(22):5424-8.
1993: A A Ross; Brenda W Cooper; H M Lazarus; W Mackay; T J Moss; N Ciobanu; Martin S Tallman; M J Kennedy; Nancy E Davidson; D Sweet
Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques.
Blood 1993;82(9):2605-10.
1993: T Tokino; Nancy E Davidson; K Helzlsouer; B Zehnbauer; Y Nakamura; Bert Vogelstein; David Sidransky
Absence of germline prohibitin mutations in early-onset breast-cancer.
International journal of oncology 1993;3(4):769-72.
1993: Scott H Kaufmann; S Desnoyers; YVONNE OTTAVIANO; Nancy E Davidson; G G Poirier
Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.
Cancer research 1993;53(17):3976-85.
1993: Nancy E Davidson; A R Mank; L J Prestigiacomo; R J Bergeron; Robert A Casero
Growth inhibition of hormone-responsive and -resistant human breast cancer cells in culture by N1, N12-bis(ethyl)spermine.
Cancer research 1993;53(9):2071-5.
1993: Nancy E Davidson; M D Abeloff
Menstrual effects on surgical treatment for breast cancer.
Cancer treatment reviews 1993;19(2):105-12.
1993: M J Kennedy; Georgia B Vogelsang; R A Beveridge; Evan Farmer; VL Altomonte; A M Huelskamp; Nancy E Davidson
Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(3):478-84.
1993: Nancy E Davidson; L J Prestigiacomo; Hillary A Hahm
Induction of jun gene family members by transforming growth factor alpha but not 17 beta-estradiol in human breast cancer cells.
Cancer research 1993;53(2):291-7.
1993: Thomas W Kensler; Nancy E Davidson; John Groopman; Bill D Roebuck; H J Prochaska; Paul Talalay
Chemoprotection by inducers of electrophile detoxication enzymes.
Basic life sciences 1993;61():127-36.
1993: A J Kronthal; elliot fishman; L M Gottlieb; Nancy E Davidson
CT evaluation of breast cancer: spectrum of disease.
Critical reviews in diagnostic imaging 1993;34(3-4):159-237.
1992: Nancy E Davidson
Biology of breast cancer and its clinical implications.
Current opinion in oncology 1992;4(6):1003-9.
1992: Deborah K Armstrong; John T Isaacs; YVONNE OTTAVIANO; Nancy E Davidson
Programmed cell death in an estrogen-independent human breast cancer cell line, MDA-MB-468.
Cancer research 1992;52(12):3418-24.
1992: David Sidransky; T Tokino; K Helzlsouer; B Zehnbauer; P. RAUSCH; B Shelton; L Prestigiacomo; Bert Vogelstein; Nancy E Davidson
Inherited p53 gene mutations in breast cancer.
Cancer research 1992;52(10):2984-6.
1992: Nancy E Davidson
Out of the courtroom and into the clinic.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(4):517-9.
1992: Nancy E Davidson
Tamoxifen--panacea or Pandora's box?
The New England journal of medicine 1992;326(13):885-6.
1992: Deborah K Armstrong; G B Gordon; John Hilton; R T Streeper; O Michael Colvin; Nancy E Davidson
Hepsulfam sensitivity in human breast cancer cell lines: the role of glutathione and glutathione S-transferase in resistance.
Cancer research 1992;52(6):1416-21.
1992: Nancy E Davidson; M D Abeloff
Adjuvant systemic therapy in women with early-stage breast cancer at high risk for relapse.
Journal of the National Cancer Institute 1992;84(5):301-5.
1992: M J Kennedy; L J Prestigiacomo; G Tyler; W S May; Nancy E Davidson
Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.
Cancer research 1992;52(5):1278-83.
1992: Nancy E Davidson; M D Abeloff
Adjuvant chemotherapy of axillary lymph-node-positive breast cancer.
Cancer treatment and research 1992;60():115-45.
1991: Nancy E Davidson
Biology of breast cancer.
Current opinion in oncology 1991;3(6):988-94.
1991: M J Kennedy; R A Beveridge; S D Rowley; G B Gordon; M D Abeloff; Nancy E Davidson
High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer.
Journal of the National Cancer Institute 1991;83(13):920-6.
1991: S D Rowley; Steven Piantadosi; D C Marcellus; Richard J Jones; Nancy E Davidson; JANICE DAVIS SPROUL; J Kennedy; J M Wiley; John R Wingard; A M Yeager
Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.
Bone marrow transplantation 1991;7(3):183-91.
1991: Natasha Kyprianou; H F English; Nancy E Davidson; John T Isaacs
Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation.
Cancer research 1991;51(1):162-6.
1990: Nancy E Davidson
Biology and prognostic factors of breast cancer.
Current opinion in oncology 1990;2(6):1025-30.
1990: J P Falco; Stephen B Baylin; R Lupu; M Borges; Barry D Nelkin; R K Jasti; Nancy E Davidson; M Mabry
v-rasH induces non-small cell phenotype, with associated growth factors and receptors, in a small cell lung cancer cell line.
The Journal of clinical investigation 1990;85(6):1740-5.
1990: Nancy E Davidson; Patricia A Egner; Thomas W Kensler
Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver.
Cancer research 1990;50(8):2251-5.
1990: M D Abeloff; R A Beveridge; Ross C Donehower; John H Fetting; Nancy E Davidson; G G Gordon; W C Waterfield; D J Damron
Sixteen-week dose-intense chemotherapy in the adjuvant treatment of breast cancer.
Journal of the National Cancer Institute 1990;82(7):570-4.
1989: J M Nigro; S J Baker; A C Preisinger; J M Jessup; R Hostetter; K Cleary; S H Bigner; Nancy E Davidson; Stephen B Baylin; P Devilee
Mutations in the p53 gene occur in diverse human tumour types.
Nature 1989;342(6250):705-8.
1989: Nancy E Davidson
Biology of breast cancer and its clinical implications.
Current opinion in oncology 1989;1(2):269-76.
1989: R B Geller; L B Boone; Judith E Karp; Nancy E Davidson; S E Selonick; J Edwards; P J Burke
Secondary acute myelocytic leukemia after adjuvant therapy for early-stage breast carcinoma. A new complication of cyclophosphamide, methotrexate, and 5-fluorouracil therapy.
Cancer 1989;64(3):629-34.
1989: Nancy E Davidson; Marc Lippman
The role of estrogens in growth regulation of breast cancer.
Critical reviews in oncogenesis 1989;1(1):89-111.
1988: Susan E Bates; Nancy E Davidson; E M Valverius; C E Freter; Robert B Dickson; J P Tam; J E Kudlow; Marc Lippman; David S Salomon
Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance.
Molecular endocrinology (Baltimore, Md.) 1988;2(6):543-55.
1987: D A Bronzert; P Pantazis; H N Antoniades; A Kasid; Nancy E Davidson; Robert B Dickson; Marc Lippman
Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(16):5763-7.
1987: Nancy E Davidson; Marc Lippman
Stimulation of breast cancer with estrogens: how much clinical value?
European journal of cancer & clinical oncology 1987;23(7):897-900.
1987: Nancy E Davidson; Edward P Gelmann; Marc Lippman; Robert B Dickson
Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines.
Molecular endocrinology (Baltimore, Md.) 1987;1(3):216-23.
1987: Marc Lippman; S Bates; K K Huff; Nancy E Davidson; R B Dickson
Estrogens regulate production of specific growth factors in hormone-dependent human breast cancer.
The Journal of laboratory and clinical medicine 1987;109(3):230-5.
1986: Thomas W Kensler; Patricia A Egner; Nancy E Davidson; Bill D Roebuck; A Pikul; John Groopman
Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases.
Cancer research 1986;46(8):3924-31.
1986: A Kasid; Nancy E Davidson; E P Gelmann; Marc Lippman
Transcriptional control of thymidine kinase gene expression by estrogen and antiestrogens in MCF-7 human breast cancer cells.
The Journal of biological chemistry 1986;261(12):5562-7.
1986: Nancy E Davidson; D A Bronzert; P Chambon; Edward P Gelmann; Marc Lippman
Use of two MCF-7 cell variants to evaluate the growth regulatory potential of estrogen-induced products.
Cancer research 1986;46(4 Pt 2):1904-8.
1986: D A Bronzert; Nancy E Davidson; Marc Lippman
Estrogen and antiestrogen resistance in human breast cancer cell lines.
Advances in experimental medicine and biology 1986;196():329-45.
1986: Marc Lippman; Robert B Dickson; A Kasid; Edward P Gelmann; Nancy E Davidson; M McManaway; K Huff; D Bronzert; S Bates; S Swain
Autocrine and paracrine growth regulation of human breast cancer.
Journal of steroid biochemistry 1986;24(1):147-54.
1985: Nancy E Davidson; Marc Lippman
Combined therapy in advanced breast cancer.
European journal of cancer & clinical oncology 1985;21(10):1123-6.
1976: Thomas W Kensler; W F Busby; Nancy E Davidson; G N Wogan
Effect of hepatocarcinogens on the binding of glucocorticoid-receptor complex in rat liver nuclei.
Cancer research 1976;36(12):4647-51.
1976: Thomas W Kensler; W F Busby; Nancy E Davidson; G N Wogan
Aflatoxin inhibition of glucocorticoid finding capacity of rat liver nuclei.
Biochimica et biophysica acta 1976;437(1):200-10.